The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
The specific disease burden of neuropathic pain: Results of a French nationwide survey
Abstract
We report the first nationwide survey of the impact of neuropathic pain, as opposed to nonneuropathic pain, on quality of life and health care utilization in the French general population. A postal questionnaire was sent to a representative sample of 4554 respondents from an initial nationwide survey of 30,155 subjects with or without chronic pain. It included pain characteristics (Neuropathic Pain Symptom Inventory, DN4), quality of life (Medical Outcomes Short Form 12, SF-12), sleep, anxiety/depressive symptoms (Hospital Anxiety and Depression Scale) and health care utilization. In total, 3899 (85.6%) questionnaires were returned, 3816 (97.9%) could be assessed and 3165 subjects (82.9%) confirmed their pain status. Subjects reporting pain and neuropathic characteristics based on the DN4 displayed a higher degree of impairment of all dimensions relating to quality of life and sleep and had higher anxiety/depression scores than those reporting pain without neuropathic characteristics and those without pain (P<.01). They also made greater use of health care facilities, particularly as concerned neurological treatments and visits to neurologists (21% vs 9%; P<.01). Multivariate analyses showed that the neuropathic characteristics of pain made an independent contribution to quality-of-life impairment (P<.0001 and P=.0005 for the physical and mental scores of the SF-12 respectively). Our study indicates that the disease burden of chronic pain depends on the nature of the pain, in…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epidemiological surveys have shown that many patients with neuropathic pain do not receive appropriate treatment for their pain.2,6,7”
From Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis (2015) · cites this paper as [2]
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.06.009 · Cited by 5,486
Pain assessment: global use of the Brief Pain Inventory.
Cs, C., & Km, R. (1994) · PubMed · Cited by 5,178
The MOS Short-form General Health Survey: Reliability and Validity in a Patient Population
Stewart, A. L., Hays, R. D., & Ware, J. E. (1988) · Medical Care · doi:10.1097/00005650-198807000-00007 · Cited by 3,339
Bouhassira, D., Attal, N., Alchaar, H., Boureau, F., Brochet, B., Bruxelle, J., Cunin, G., Fermanian, J., Giniès, P., Grun-Overdyking, A., et al. (2005) · Pain · doi:10.1016/j.pain.2004.12.010 · Cited by 2,834
Self-citationTreede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Self-citationPrevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri‐Minet, M., Attal, N., Laurent, B., & Touboul, C. (2007) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,827
Self-citationNeuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
Baron, R., Binder, A., & Wasner, G. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70143-5 · Cited by 1,816
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–426 of 426
Cross-sectional comparison of cannabis use in adults with neuropathic versus non-neuropathic pain
Laroya, C. J., Smith, C. L., Bindler, R. J., McDonell, M. G., Lewis, J., & Wilson, M. (2025) · Frontiers in Pain Research · doi:10.3389/fpain.2025.1677391
Todeschi, J., Dannhoff, G., Coca, A. H., Timbolschi, D. I., Proust, F., Lefebvre, F., Lelièvre, V., Poisbeau, P., Vallat, L. D., Salvat, É., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23542906
Broberg, M. E., Gen, F., Kalso, E., & Ollila, H. M. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf200
Bohren, Y., & Petitjean, H. (2026) · Douleurs Évaluation - Diagnostic - Traitement · doi:10.1016/j.douler.2025.10.004
Affective Symptoms as Neglected Outcomes in Neuropathic Pain Trials
João, R. B., ARAÚJO, L. M., Chan, J. O. T., João, A. B., & Dantas, J. M. (2026) · European Journal of Pain · doi:10.1002/ejp.70232
Neuropathic Pain: Pathophysiology, Current Treatment, and Future Directions
Elkholy, N., Safwan, H., Rihan, N. F., Abdelwaly, A., & Helal, M. A. (2026) · Science and Technology Nexus · doi:10.25259/stn_22_2025
TABACOF, L. R., Howard, R., Bower, J. D., Canori, A., Bond, N., Breyman, E., Dewil, S., Tosto-Mancuso, J., Hanbury, R., Carmouche, B., et al. (2026) · BMC Neurology · doi:10.1186/s12883-026-04785-w
Perineural Administration of Botulinum Toxin for Chronic Pain Management: A Narrative Review
Belaise, T., Kremer, M., Poulain, B., Yalçın, İ., & Bohren, Y. (2026) · Pain Research and Management · doi:10.1155/prm/6539538
Delta opioid receptor expression in various models of chronic clinical conditions
Ceredig, R. A. (2016) · theses.fr (ABES) · doi:10.70675/e750f280zf542z480dz8e6czab49ecd74230
The ACC is a critical hub for neuropathic pain-induced depression
Sellmeijer, J. (2016) · theses.fr (ABES) · doi:10.70675/a4602e02z1c7az4a9dzb530z78a0ad19a0b8
Triaux, Z. (2019) · theses.fr (ABES) · doi:10.70675/608b6e98z5d41z4297za08cz8a7ef57950c3
Neuropathic pain and depression : molecular alterations in the anterior cingulate cortex
Humo, M. (2019) · theses.fr (ABES) · doi:10.70675/e72f9364z66cbz45c4z8b42zb7f3564cd3d0
Le récepteur 5-HT6, une nouvelle cible pour le traitement des douleurs neuropathiques
Martin, P.-Y. (2018) · theses.fr (ABES) · doi:10.70675/07f1c1dcz43f2z4752zbafcz43480dae7825
Quesada, C. (2018) · theses.fr (ABES) · doi:10.70675/fe7c32d5z5575z4df5z8fa0zdb29dd30171e
Naïditch, N. (2020) · theses.fr (ABES) · doi:10.70675/e843388ezd42cz4292zaf5bz52ef076ba780
Contribution of the amygdalo-cingulate pathway in depression and its comorbidity with chronic pain
Becker, L. J. (2021) · theses.fr (ABES) · doi:10.70675/cdeda10fz3bbdz4a8cza740z361352fc379b
Menéndez-Cámara, J., Arribas‐Romano, A., González‐Zamorano, Y., Valverde-Aranda, M., Gurdiel‐Álvarez, F., de la Rosa-Díaz, I., Matesanz-García, L., & Fernández‐Carnero, J. (2026) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2026.04.017
Attal, N., Branders, S., Pereira, A., & Bouhassira, D. (2026) · NeuroTarget · doi:10.47924/neurotarget2026604
Self-citationArnold, K., Al-Chalabi, N., Mann, M., Liu, T., Husain, M. I., Rosenbloom, B. N., & Ladha, K. (2026) · Pain · doi:10.1097/j.pain.0000000000004002
Giovannico, G., Pellicciari, L., Cacciola, F., Bianco, A., Rinaldi, D., Laricchiuta, P., Giannotta, G., & Angilecchia, D. (2026) · Disability and Rehabilitation · doi:10.1080/09638288.2026.2672855
Zajączkowska, R., Ciechanowska, A., Pawlik, K., Ciapała, K., Makuch, W., Wordliczek, J., Kocot-Kępska, M., & Mika, J. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00862-6
Sumimoto, T., Yoshikawa, N., Tatsuta, R., Tanaka, R., & Itoh, H. (2026) · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · doi:10.5649/jjphcs.52.427
Attal, N., & Spagna, A. (2025) · Dunod eBooks · doi:10.3917/dunod.poisb.2025.01.2008
Self-citationEngineering Nanoscale Drug Delivery Systems for Pain
Pollard, R. E., Moreno, A. S., Hempstead, V. M., Hégron, A., Lewis, P. K., Bahrami, K., Sokrat, B., Schmidt, B. L., Bunnett, N. W., Jensen, D. D., et al. (2026) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70072
Metadata
- Authors
- Attal, N., Lanteri-Minet, M., Laurent, B., Fermanian, J., & Bouhassira, D.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Inserm (FR)
- Corresponding author
- Attal, Nadine
- Venue
- Pain
- Published
- 2011-12
- Volume
- 152
- Issue
- 12
- Pages
- 2836-2843
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2083463729
- Cited by
- 427
- References
- 37
- Citations by year
- 2026: 16 · 2025: 28 · 2024: 31 · 2023: 38 · 2022: 34 · 2021: 53 · 2020: 27 · 2019: 29 · 2018: 39 · 2017: 23 · 2016: 24 · 2015: 24 · 2014: 24 · 2013: 23 · 2012: 12
- FWCI
- 12.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pain (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Keywords
- neuropathic pain, chronic pain, disease burden, quality of life, health care utilization, sleep disorders, anxiety and depression, pain characteristics
- MeSH terms
- Adult, Aged, Female, France, Health Surveys, Humans, Male, Middle Aged, Neuralgia, Quality of Life, Surveys and Questionnaires, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review